Société Générale Société anonyme (SGE)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 59.63 |
|---|---|
| 52-week range | 52.38 – 84.78 |
| Return, 1 month / 3 months | −16.5% / −20.4% |
| Return, 1 year / 3 years | +14.2% / +211.0% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 34.9% |
| Worst drawdown (1 year) | -28.4% |
| Average daily value traded | 0.44M EUR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Société Générale is a French banking group based in Paris. It provides retail banking services to individual customers and small businesses, mainly through its branch network in France, and offers corporate and investment banking, financing and advisory services to large companies and institutional clients. The group also runs asset management and insurance activities and serves customers in several countries outside France. Its business spans everyday banking, lending, payments and capital markets services for a broad range of clients.
Société Générale Société anonyme trades under the code SGE on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Société Générale Société anonyme (SGE) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 59.63 on 23 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 406 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.2% and over the last three months it fell 20.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 36 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.4% | ||
| From 52-week high | -29.2% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.4% | ||
| 6-month return | -12.2% | ||
| 12-month return, skipping the last month | 36.8% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.4% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.44M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −7.6% |
|---|---|
| 1 month | −16.5% |
| 3 months | −20.4% |
| 6 months | −12.2% |
| 1 year | +14.2% |
| 3 years | +211.0% |
| 5 years | +164.2% |
Signals
| 50-day / 200-day average | 69.83 / 70.52 |
|---|---|
| Golden / death cross (60 days) | Death, 1 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.79 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Oct 2026 | EUR 0.7500 |
| 1 Jun 2026 | EUR 1.0000 |
| 7 Oct 2025 | EUR 0.6100 |
| 26 May 2025 | EUR 1.0900 |
| 27 May 2024 | EUR 0.9000 |
| 30 May 2023 | EUR 1.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.